Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy). Read more
25 Nov 2024
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). Read more
17 Oct 2024
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
EPM's new prescription
Olivia Friett introduces herself as the new editor of European Pharmaceutical Manufacturer. Read more
5 Dec 2024
The role of alarm annunciators in preserving life-saving medication
Ian Loudon, international sales and marketing manager at alarm annunciator specialist Omniflex, explores the importance of alarm annunciators in monitoring the temperature in pharmaceutical and laboratory environments. Read more
4 Dec 2024
Planova FG1 brings a step forward in biopharma manufacturing
Koki Obara, marketing manager, Asahi Kasei Medical, delves into the current biopharmaceutical environment, the critical role of virus removal filters, and how Planova FG1 stands to impact the development and production of biopharmaceuticals. Read more
3 Dec 2024
Q&A: Ending plastics pollution
After IFPMA, GSCF, and IGBA submitted a joint opening statement at the fifth session of the Intergovernmental Negotiating Committee (INC-5), European Pharmaceutical Manufacturer spoke to Melchior Kuo, manager, Innovation and Vaccine Policy, IFPMA. Read more
3 Dec 2024
Q&A: ACG expands in Croatia
After ACG announced the expansion in Croatia, European Pharmaceutical Manufacturer spoke to the company to discuss what it means for it's growth. Read more
2 Dec 2024
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Q&A: Syvento Biotech and Cytiva opening a new FlexFactory
After hearing the news of Cytiva and Syvento Bitotech's new facility, European Pharmaceutical Manufacturer followed up with Ludovic Brellier, president of Hardware Solutions at Cytiva, for more information. Read more
27 Nov 2024
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights